Clinical trials - Press Releases

Date	Title	Company
17-Jun-2021	Analysis of COVID-19 on global Online Fitness Course Market 2021 by Scope, Size, Share, Overview, Supply Demand and Shortage, Trends, Demand, Forecast to 2026	Analytical Research Cognizance
17-Jun-2021	Freeline Doses Second Patient of Phase 1/2 MARVEL-1 Clinical Trial for Fabry Disease	Freeline Therapeutics Holdings
17-Jun-2021	Neurosurgery Devices Market to Reach USD 13.5 billion by 2024 – Expanding Applications and Technological Advancement	MarketsandMarkets Research Private Ltd.
17-Jun-2021	Neuromodulation Market to Reach USD 8.8 billion by 2025 – Emerging and Expanding Application	MarketsandMarkets Research Private Ltd.
17-Jun-2021	3D Cell Culture Market to Reach USD 1846 million by 2024 – Growing Focus on Personalized Medicine	MarketsandMarkets Research Private Ltd.
17-Jun-2021	Biogen Announces Topline Results From Phase 2 Study of Gosuranemab, an Anti-Tau Antibody, for Alzheimer’s Disease	Biogen
17-Jun-2021	CureVac gibt Status-Update zur Phase 2b/3-Studie für Impfstoffkandidat der ersten Generation CVnCoV bekannt	CureVac
17-Jun-2021	Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional Deep Brain Stimulation System	Aleva Neurotherapeutics
16-Jun-2021	Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling	Olink Holding AB
16-Jun-2021	Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day Nurtec® ODT for the Preventive Treatment of Migraine	Lilly
16-Jun-2021	Global Brain Natriuretic Peptide (BNP) Test Market 2021 Trends, Demand and Scope with Outlook, Business Strategies and Forecast 2027	Axel Reports
15-Jun-2021	Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59), an anti-COVID-19 monoclonal antibody treatment	Celltrion
15-Jun-2021	Trialbee and uMotif Simplify and Expand Patient Access to Global Clinical Trials	TrialBee
15-Jun-2021	Digital Diabetes Management Market Worth USD 19.9 billion – Growing Adoption of Wearable Devices for Diabetes Management	MarketsandMarkets Research Private Ltd.
15-Jun-2021	Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial	Novavax
15-Jun-2021	Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously	Novavax
15-Jun-2021	Biogen Announces Topline Results from Phase 3 Gene Therapy Study in Choroideremia	Biogen
14-Jun-2021	Gram-Positive Bacterial Infections Market - Positive infections in critically ill patients \| Detailed Study by Coherent Market Insights with Upcoming Trends	Coherent Market Insights
14-Jun-2021	Clinical Trial Supplies Market - Emerging Trends & Future Forecasts	MarketsandMarkets Research Private Ltd.
11-Jun-2021	betibeglogene autotemcel (beti-cel) One-Time Gene Therapy for β-thalassaemia Continues to Demonstrate Durable Efficacy Across Paediatric and Adult Patient Populations and All Genotypes in Data Presented at EHA2021 Virtual	bluebird bio